Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Advances in drug delivery for post-surgical cancer treatment.

Bu LL, Yan J, Wang Z, Ruan H, Chen Q, Gunadhi V, Bell RB, Gu Z.

Biomaterials. 2019 Oct;219:119182. doi: 10.1016/j.biomaterials.2019.04.027. Epub 2019 Apr 28. Review.

PMID:
31415954
2.

Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook.

Talebian S, Foroughi J, Wade SJ, Vine KL, Dolatshahi-Pirouz A, Mehrali M, Conde J, Wallace GG.

Adv Mater. 2018 Aug;30(31):e1706665. doi: 10.1002/adma.201706665. Epub 2018 May 13. Review.

PMID:
29756237
3.

Advances in immunotherapy delivery from implantable and injectable biomaterials.

Leach DG, Young S, Hartgerink JD.

Acta Biomater. 2019 Apr 1;88:15-31. doi: 10.1016/j.actbio.2019.02.016. Epub 2019 Feb 13. Review.

4.

Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery.

Goldberg EP, Hadba AR, Almond BA, Marotta JS.

J Pharm Pharmacol. 2002 Feb;54(2):159-80. Review.

PMID:
11848280
5.

Medical Error Prevention.

Rodziewicz TL, Hipskind JE.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 5.

6.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
7.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
8.

Advances in drug delivery systems (DDSs) to release growth factors for wound healing and skin regeneration.

Gainza G, Villullas S, Pedraz JL, Hernandez RM, Igartua M.

Nanomedicine. 2015 Aug;11(6):1551-73. doi: 10.1016/j.nano.2015.03.002. Epub 2015 Mar 21. Review.

PMID:
25804415
9.

Patterns of failure following surgical resection for malignant pleural mesothelioma.

Jänne PA, Baldini EH.

Thorac Surg Clin. 2004 Nov;14(4):567-73. Review.

PMID:
15559064
10.

Clinical Considerations of Focal Drug Delivery in Cancer Treatment.

Harris J, Klonoski SC, Chiu B.

Curr Drug Deliv. 2017;14(5):588-596. doi: 10.2174/1567201814666170224143706. Review.

PMID:
28240175
11.

Designing Hydrogels for On-Demand Therapy.

Oliva N, Conde J, Wang K, Artzi N.

Acc Chem Res. 2017 Apr 18;50(4):669-679. doi: 10.1021/acs.accounts.6b00536. Epub 2017 Mar 16. Review.

12.

Nanotherapeutic systems for local treatment of brain tumors.

Chakroun RW, Zhang P, Lin R, Schiapparelli P, Quinones-Hinojosa A, Cui H.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jan;10(1). doi: 10.1002/wnan.1479. Epub 2017 May 24. Review.

13.

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.

14.

An Overview of Drug Delivery Systems.

Jain KK.

Methods Mol Biol. 2020;2059:1-54. doi: 10.1007/978-1-4939-9798-5_1.

PMID:
31435914
15.

Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.

Lei K, Tang L.

Biomater Sci. 2019 Feb 26;7(3):733-749. doi: 10.1039/c8bm01470a. Review.

PMID:
30637428
16.

Novel targeted bladder drug-delivery systems: a review.

Zacchè MM, Srikrishna S, Cardozo L.

Res Rep Urol. 2015 Nov 23;7:169-78. doi: 10.2147/RRU.S56168. eCollection 2015. Review.

17.

More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

PMID:
30843003
18.

Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era.

Klener P Jr, Etrych T, Klener P.

Curr Med Chem. 2019;26(6):1002-1018. doi: 10.2174/0929867324666171006144725. Review.

PMID:
28990505
19.

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP.

CA Cancer J Clin. 2018 Nov;68(6):488-505. doi: 10.3322/caac.21498. Epub 2018 Oct 17. Review.

20.

Polymeric drug delivery for the treatment of glioblastoma.

Wait SD, Prabhu RS, Burri SH, Atkins TG, Asher AL.

Neuro Oncol. 2015 Mar;17 Suppl 2:ii9-ii23. doi: 10.1093/neuonc/nou360. Review.

Supplemental Content

Support Center